For COVID-19 and vaccination updates, view our information for the community. If you're experiencing symptoms, call your primary care provider.

Decorative dot pattern background image.
Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image.

Biodesix, Inc. BDX-00146

Trial Overview

Official Title

An observational study assessing the clinical effectiveness of the VeriStrat test and validation immunotherapy tests in subjects with non-small cell lung cancer

Study Purpose

To collect information about how the study doctor uses the results of the VeriStrat blood test to choose treatment for NSCLC.

Diagnosis

Non-small cell lung cancer.

Eligibility

No prior treatment necessary.

Patients must sign an approved informed consent and authorization permitting release of personal health information.

Intervention

  • There are no required treatments for this study, only blood draws and results. 
  • If EGFR gene status is unknown, additional blood will be drawn for testing.

Involvement in this study will last for 18 months.

For more information, visit ClinicalTrials.gov

Key Participation Requirements
Gender
Male or Female
Age
19 years and older
Enrollment Status
Recruiting
Phase
Not Applicable
Methodist Health System Trial Code
BDX-00146